KSE - Delayed Quote KRW

Amorepacific Corporation (090430.KS)

Compare
105,100.00 -3,000.00 (-2.78%)
At close: December 27 at 3:30:17 PM GMT+9
Loading Chart for 090430.KS
DELL
  • Previous Close 108,100.00
  • Open 106,900.00
  • Bid 104,800.00 x --
  • Ask 104,900.00 x --
  • Day's Range 103,600.00 - 108,400.00
  • 52 Week Range 99,500.00 - 200,500.00
  • Volume 209,637
  • Avg. Volume 298,327
  • Market Cap (intraday) 6.484T
  • Beta (5Y Monthly) 1.11
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date Jan 28, 2025 - Feb 3, 2025
  • Forward Dividend & Yield 910.00 (0.83%)
  • Ex-Dividend Date Dec 27, 2023
  • 1y Target Est 165,928.58

Amorepacific Corporation researches, develops, manufactures, markets, and sells cosmetics and beauty products worldwide. The company operates through Cosmetics and Daily Beauty segments. It offers skin and personal care, cosmetics, perfume, medical beauty, beauty device, inner beauty, hair care, body care, tea culture, and dental care products, as well as cleaners under various brands. The company also manufactures and sells organic and inorganic chemicals. It offers its beauty products through stores and online. The company was founded in 1945 and is headquartered in Seoul, South Korea.

www.apgroup.com

4,349

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 090430.KS

View More

Performance Overview: 090430.KS

Trailing total returns as of 12/27/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

090430.KS
27.52%
KOSPI Composite Index
9.43%

1-Year Return

090430.KS
23.73%
KOSPI Composite Index
7.99%

3-Year Return

090430.KS
38.74%
KOSPI Composite Index
19.83%

5-Year Return

090430.KS
44.96%
KOSPI Composite Index
9.10%

Compare To: 090430.KS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 090430.KS

View More

Valuation Measures

As of 12/27/2024
  • Market Cap

    6.48T

  • Enterprise Value

    6.28T

  • Trailing P/E

    10.50

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.95

  • Price/Book (mrq)

    1.36

  • Enterprise Value/Revenue

    1.69

  • Enterprise Value/EBITDA

    10.42

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    18.75%

  • Return on Assets (ttm)

    1.13%

  • Return on Equity (ttm)

    13.27%

  • Revenue (ttm)

    3.63T

  • Net Income Avi to Common (ttm)

    653.21B

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    673.87B

  • Total Debt/Equity (mrq)

    7.00%

  • Levered Free Cash Flow (ttm)

    282.2B

Research Analysis: 090430.KS

View More

People Also Watch